Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
Provided By GlobeNewswire
Last update: Oct 15, 2025
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital
Plans to Commence Tender Offer to Repurchase up to $194 Million of Additional Shares
Read more at globenewswire.com
